Showing results (21-30 of 502) with videos related to
Sort By:
Pageof 51
Contemporary Clinical Trials|January 5, 2011
Bayesian sample size determination under hypothesis testsXiao Zhang, Gary Cutter, Thomas BelinMultiple Sclerosis and Related Disorders|May 27, 2015
Risk tolerance to MS therapies: Survey results from the NARCOMS registryRobert J Fox, Amber Salter, Joan M Alster, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 17, 2011
Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosisRuth Ann Marrie, Gary Cutter, Tuula TyryMultiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2017
Clinical trial design for progressive MS trialsMatteo Pardini, Gary Cutter, Maria Pia SormaniMuscle & Nerve|November 2, 2022
The best and worst of times in therapy development for myasthenia gravisMichael Benatar, Gary Cutter, Henry J KaminskiNeurology|December 10, 2003
Effect of relapses on development of residual deficit in multiple sclerosisFred D Lublin, Monika Baier, Gary CutterKidney360|April 4, 2022
Arteriovenous Fistula Nonmaturation: What's the Immune System Got to Do with It?Crystal A Farrington, Gary Cutter, Michael AllonBiometrics|March 2, 2005
Assessing accuracy of mammography in the presence of verification bias and intrareader correlationYingye Zheng, William E Barlow, Gary CutterCurrent Opinion in Neurology|April 6, 2019
Multiple sclerosis: clinical trial design 2019Matteo Pardini, Gary Cutter, Maria Pia SormaniMultiple Sclerosis (Houndmills, Basingstoke, England)|January 6, 2021
An enrichment strategy for clinical trials in SPMSMarcus W Koch, Luanne Metz, Gary CutterPageof 51